ArticleVox sanguinis2022

Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products.

Filippo Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.